Abeona Therapeutics (ABEO) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart

Abeona Therapeutics Revenue Highlights

Latest Revenue (Y)

$3.50M

Main Segment (Y)

License and Other Revenues

Main Geography (Y)

License and Other Revenues

Abeona Therapeutics Revenue by Period

Abeona Therapeutics Revenue by Year

Date	Revenue	Change
2023-12-31	$3.50M	147.52%
2022-12-31	$1.41M	-52.87%
2021-12-31	$3.00M	-70.00%
2020-12-31	$10.00M	100.00%
2019-12-31	-	-100.00%
2018-12-31	$3.00M	258.18%
2017-12-31	$837.00K	-5.85%
2016-12-31	$889.00K	-14.52%
2015-12-31	$1.04M	12.43%
2014-12-31	$925.00K	-54.70%
2013-12-31	$2.04M	-53.63%
2012-12-31	$4.40M	138.31%
2011-12-31	$1.85M	284.20%
2010-12-31	$481.00K	36.65%
2009-12-31	$352.00K	20.96%
2008-12-31	$291.00K	410.53%
2007-12-31	$57.00K	100.00%
2006-12-31	-	100.00%
2005-12-31	-	-100.00%
2004-12-31	$549.00K	-57.61%
2003-12-31	$1.29M	12.90%
2002-12-31	$1.15M	372.02%
2001-12-31	$243.00K	127.10%
2000-12-31	$107.00K	613.33%
1999-12-31	$15.00K	-85.00%
1998-12-31	$100.00K	-77.01%
1997-12-31	$435.00K	160.48%
1996-12-31	$167.00K	-94.33%
1995-12-31	$2.94M	-

Abeona Therapeutics generated $3.50M in revenue during NA 2023, up 147.52% compared to the previous quarter, and up 116.74% compared to the same period a year ago.

Abeona Therapeutics Revenue by Quarter

Date	Revenue	Change
2024-06-30	-	100.00%
2024-03-31	-	-100.00%
2023-12-31	$2.82M	100.00%
2023-09-30	-	-100.00%
2023-06-30	$3.50M	100.00%
2023-03-31	-	-100.00%
2022-12-31	$68.00K	100.00%
2022-09-30	-	-100.00%
2022-06-30	$1.00M	189.02%
2022-03-31	$346.00K	-88.47%
2021-12-31	$3.00M	100.00%
2021-09-30	-	100.00%
2021-06-30	-	100.00%
2021-03-31	-	-100.00%
2020-12-31	$3.00M	-57.14%
2020-09-30	$7.00M	100.00%
2020-06-30	-	100.00%
2020-03-31	-	100.00%
2019-12-31	-	100.00%
2019-09-30	-	100.00%
2019-06-30	-	100.00%
2019-03-31	-	-100.00%
2018-12-31	$-2.13M	-224.52%
2018-09-30	$1.71M	108.67%
2018-06-30	$819.00K	-68.48%
2018-03-31	$2.60M	1108.37%
2017-12-31	$215.00K	-1.83%
2017-09-30	$219.00K	0.92%
2017-06-30	$217.00K	16.67%
2017-03-31	$186.00K	-27.34%
2016-12-31	$256.00K	39.13%
2016-09-30	$184.00K	-14.02%
2016-06-30	$214.00K	-8.94%
2016-03-31	$235.00K	9.30%
2015-12-31	$215.00K	-24.56%
2015-09-30	$285.00K	1.06%
2015-06-30	$282.00K	9.30%
2015-03-31	$258.00K	10.26%
2014-12-31	$234.00K	-0.85%
2014-09-30	$236.00K	-4.45%
2014-06-30	$247.00K	18.75%
2014-03-31	$208.00K	28.40%
2013-12-31	$162.00K	-14.29%
2013-09-30	$189.00K	-59.53%
2013-06-30	$467.00K	-61.85%
2013-03-31	$1.22M	21.67%
2012-12-31	$1.01M	15.50%
2012-09-30	$871.00K	26.23%
2012-06-30	$690.00K	-62.80%
2012-03-31	$1.85M	266.60%
2011-12-31	$506.00K	-51.39%
2011-09-30	$1.04M	589.40%
2011-06-30	$151.00K	0.67%
2011-03-31	$150.00K	2.04%
2010-12-31	$147.00K	15.75%
2010-09-30	$127.00K	20.95%
2010-06-30	$105.00K	2.94%
2010-03-31	$102.00K	-1.92%
2009-12-31	$104.00K	-27.78%
2009-09-30	$144.00K	128.57%
2009-06-30	$63.00K	53.66%
2009-03-31	$41.00K	-44.59%
2008-12-31	$74.00K	57.45%
2008-09-30	$47.00K	-64.39%
2008-06-30	$132.00K	247.37%
2008-03-31	$38.00K	-25.49%
2007-12-31	$51.00K	-

Abeona Therapeutics generated - in revenue during Q2 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Abeona Therapeutics Revenue Breakdown

Abeona Therapeutics Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 21	Dec 20	Dec 18
License and Other Revenues	$3.00M	$10.00M	-
Foundation	-	-	$5.71M
License	-	-	$602.00K

Abeona Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 21: License and Other Revenues (100.00%).

Quarterly Revenue by Product

Product/Service	Dec 18	Sep 18	Jun 18
Royalty	$113.00K	$22.00K	$17.00K
Grant	$369.00K	$1.69M	$802.00K

Abeona Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Dec 18: Grant (76.56%), and Royalty (23.44%).

Abeona Therapeutics Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 21	Dec 20	Dec 18
License and Other Revenues	$3.00M	$10.00M	-
License	-	-	$602.00K
Foundation	-	-	$5.71M

Abeona Therapeutics's latest annual revenue breakdown by geography, as of Dec 21: License and Other Revenues (100.00%).

Quarterly Revenue by Country

Country	Dec 18	Sep 18	Jun 18
Royalty	$113.00K	$22.00K	$17.00K
Grant	$369.00K	$1.69M	$802.00K

Abeona Therapeutics's latest quarterly revenue breakdown by geography, as of Dec 18: Grant (76.56%), and Royalty (23.44%).

Abeona Therapeutics Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
ACAD	ACADIA Pharmaceuticals	$726.44M	$250.40M
RGNX	REGENXBIO	$90.24M	$24.20M
ADAP	Adaptimmune Therapeutics	$60.28M	$128.23M
FBIO	Fortress Biotech	$59.66M	$14.63M
PIRS	Pieris Pharmaceuticals	$42.81M	-
MREO	Mereo BioPharma Group	$10.00M	-
AFMD	Affimed	$8.28M	$155.00K
ABEO	Abeona Therapeutics	$3.50M	-
CKPT	Checkpoint Therapeutics	$103.00K	-
ANEB	Anebulo Pharmaceuticals	-	-
BDTX	Black Diamond Therapeutics	-	-
XFOR	X4 Pharmaceuticals	-	$560.00K
CABA	Cabaletta Bio	-	-
RVPH	Reviva Pharmaceuticals	-	-
PDSB	PDS Bio	-	-
DAWN	Day One Biopharmaceuticals	-	$20.07M
INZY	Inozyme Pharma	-	-
LPTX	Leap Therapeutics	-	-
ATHA	Athira Pharma	-	-
TERN	Terns Pharmaceuticals	-	-
IVVD	Invivyd	-	-

ABEO Revenue FAQ

What is Abeona Therapeutics’s yearly revenue?

Abeona Therapeutics's yearly revenue for 2023 was $3.5M, representing an increase of 147.52% compared to 2022. The company's yearly revenue for 2022 was $1.41M, representing a decrease of -52.87% compared to 2021. ABEO's yearly revenue for 2021 was $3M, representing a decrease of -70.00% compared to 2020.

What is Abeona Therapeutics’s quarterly revenue?

Abeona Therapeutics's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a -100.00% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). ABEO's quarterly revenue for Q4 2023 was $2.82M, a 100.00% increase from the previous quarter (Q3 2023), and a 4052.94% increase year-over-year (Q4 2022).

What is Abeona Therapeutics’s revenue growth rate?

Abeona Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 16.67%, and for the last 5 years (2019-2023) was 0%.

What are Abeona Therapeutics’s revenue streams?

Abeona Therapeutics's revenue streams in c 21 are License and Other Revenues

What is Abeona Therapeutics’s main source of revenue?

For the fiscal year ending Dec 21, the largest source of revenue of Abeona Therapeutics was License and Other Revenues. This segment made a revenue of $3M, representing 100.00% of the company's total revenue.